Apellis, Sobi's 'enormous' Empaveli win could pressure Novartis in rare kidney diseases: analyst

Apellis, Sobi's 'enormous' Empaveli win could pressure Novartis in rare kidney diseases: analyst zbecker Thu, 08/08/2024 - 10:58